Edgewise Therapeutics Statistics

Total Valuation

EWTX has a market cap or net worth of $1.72 billion. The enterprise value is $1.19 billion.

Market Cap	1.72B
Enterprise Value	1.19B

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, before market open.

Earnings Date	Aug 8, 2024
Ex-Dividend Date	n/a

Share Statistics

EWTX has 93.40 million shares outstanding. The number of shares has increased by 38.41% in one year.

Shares Outstanding	93.40M
Shares Change (YoY)	+38.41%
Shares Change (QoQ)	+35.16%
Owned by Insiders (%)	0.47%
Owned by Institutions (%)	109.00%
Float	52.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.21
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 37.08, with a Debt / Equity ratio of 0.01.

Current Ratio	37.08
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -29.10% and return on invested capital (ROIC) is -22.84%.

Return on Equity (ROE)	-29.10%
Return on Assets (ROA)	-27.60%
Return on Capital (ROIC)	-22.84%
Revenue Per Employee	n/a
Profits Per Employee	-$1.20M
Employee Count	88
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +143.77% in the last 52 weeks. The beta is 0.13, so EWTX's price volatility has been lower than the market average.

Beta (5Y)	0.13
52-Week Price Change	+143.77%
50-Day Moving Average	17.75
200-Day Moving Average	13.08
Relative Strength Index (RSI)	55.67
Average Volume (20 Days)	897,794

Short Selling Information

The latest short interest is 7.62 million, so 8.16% of the outstanding shares have been sold short.

Short Interest	7.62M
Short Previous Month	6.50M
Short % of Shares Out	8.16%
Short % of Float	14.56%
Short Ratio (days to cover)	13.88

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-123.41M
Pretax Income	-105.85M
Net Income	-105.85M
EBITDA	-103.83M
EBIT	-105.85M
Earnings Per Share (EPS)	-$1.55

Full Income Statement

Balance Sheet

The company has $532.76 million in cash and $5.25 million in debt, giving a net cash position of $527.51 million or $5.65 per share.

Cash & Cash Equivalents	532.76M
Total Debt	5.25M
Net Cash	527.51M
Net Cash Per Share	$5.65
Equity (Book Value)	534.94M
Book Value Per Share	5.73
Working Capital	526.83M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$97.72 million and capital expenditures -$1.67 million, giving a free cash flow of -$99.39 million.

Operating Cash Flow	-97.72M
Capital Expenditures	-1.67M
Free Cash Flow	-99.39M
FCF Per Share	-$1.14

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

EWTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.41%
Shareholder Yield	-38.41%
Earnings Yield	-6.17%
FCF Yield	-5.79%

Analyst Forecast

The average price target for EWTX is $34.00, which is 84.98% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$34.00
Price Target Difference	84.98%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-26.96%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3